WILLIAM S. REARDON, MBA

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

abrdn Life Sciences Investors

Filing Date Source Excerpt
2021-04-13 William S. Reardon: Mr. Reardon serves on the Valuation Committee and as Chair of the Audit Committee and the Qualified Legal Compliance Committee of each Fund. For the fiscal year ended September 30, 2020, the Independent Trustees as a group received $107,000 for Mr. Reardon.

Data sourced from SEC filings. Last updated: 2026-02-03